McKesson recalls

McKesson has 12 recalls on record with the FDA and USDA, the earliest in 2014 and the latest reported on 8 Jul 2026. 8 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls12since 2014

Last 12 months2reported

Class I18% of total

Ongoing8latest 8 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 1Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 1Feb 0 0 0May 0 1 0Aug 0 0

Severity split

Class I 1 8%Class II 10 83%Class III 1 8%

Why mckesson is recalled

Product types

Brands

By year

2026217%
202518%
202418%
2022542%
202118%
201818%
201418%

Ongoing mckesson recalls

8 active

Reported	Class	Recall	Company	Reason	Where
8 Jul 2026Drug	CLASS II	Gemcitabine Injection per (38 mg/mL) Single-Dose Vial recalledGemcitabine	McKesson	Temperature Abuse	Nationwide
18 Feb 2026Drug	CLASS I	Udenyca, pegfilgrastim-cbqv injection recalled by McKessonUdenyca	McKesson	Temperature Abuse	Nationwide
5 Feb 2025Drug	CLASS II	Inflectra (infliximab-dyyb), For injection, 100mg per vial recalledInflectra	McKesson	Manufacturing (CGMP) Deviations	Nationwide
11 May 2022Drug	CLASS II	Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented) recalled	McKesson	Potency & Assay	Nationwide
11 May 2022Drug	CLASS II	Lidocaine Prilocaine Cream USP, 2.5%/2.5% recalled by McKesson	McKesson	Potency & Assay	Nationwide
11 May 2022Drug	CLASS II	Halobetasol Propionate Ointment recalled by McKesson	McKesson	Potency & Assay	Nationwide

All mckesson recalls, newest first

12 total

Reported	Class	Recall	Company	Reason	Where
8 Jul 2026Drug	CLASS II	Gemcitabine Injection per (38 mg/mL) Single-Dose Vial recalledGemcitabine	McKesson	Temperature Abuse	Nationwide
18 Feb 2026Drug	CLASS I	Udenyca, pegfilgrastim-cbqv injection recalled by McKessonUdenyca	McKesson	Temperature Abuse	Nationwide
5 Feb 2025Drug	CLASS II	Inflectra (infliximab-dyyb), For injection, 100mg per vial recalledInflectra	McKesson	Manufacturing (CGMP) Deviations	Nationwide
28 Feb 2024Drug	CLASS II	Cabtreo (clindamycin phosphate, adapalene recalled by MckessonCabtreo	Mckesson	Manufacturing (CGMP) Deviations	Nationwide
11 May 2022Drug	CLASS II	Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented) recalled	McKesson	Potency & Assay	Nationwide
11 May 2022Drug	CLASS II	Lidocaine Prilocaine Cream USP, 2.5%/2.5% recalled by McKesson	McKesson	Potency & Assay	Nationwide
11 May 2022Drug	CLASS II	Halobetasol Propionate Ointment recalled by McKesson	McKesson	Potency & Assay	Nationwide
11 May 2022Drug	CLASS II	Erythromycin Topical Gel recalled by McKesson	McKesson	Potency & Assay	Nationwide
11 May 2022Drug	CLASS II	Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL) recalled	McKesson	Potency & Assay	Nationwide
16 Jun 2021Drug	CLASS III	Levetiracetam Tablets USP, 250 mg UD recalled by McKesson	McKesson	Other	Nationwide
12 Sep 2018Drug	CLASS II	Megestrol Acetate Oral Suspension, USP 400 mg/mL UD cups in boxes recalled	Mckesson	Packaging Defects	Nationwide
15 Oct 2014Drug	CLASS II	Amiodarone HCl Injection, 450 mg/ (50 mg per mL) Single-Use Vial recalledAmiodarone Hydrochloride	Mckesson	Temperature Abuse	MT, OR, WA

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.